|
|
Volumn 13, Issue 2, 2008, Pages 50-
|
|
Review: β-blockers for hypertension increase risk of new onset diabetes: Commentary
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
CHLORTALIDONE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOXAZOSIN;
LISINOPRIL;
PLACEBO;
THIAZIDE DIURETIC AGENT;
TRIACYLGLYCEROL;
ABDOMINAL OBESITY;
ANGIONEUROTIC EDEMA;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG FATALITY;
DRUG SURVEILLANCE PROGRAM;
EDEMA;
EMBASE;
EVIDENCE BASED MEDICINE;
FOLLOW UP;
HEART INFARCTION;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
HYPERTRIGLYCERIDEMIA;
INCIDENCE;
INDIVIDUALIZATION;
MEDICAL DECISION MAKING;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
MEDLINE;
METABOLIC DISORDER;
METABOLIC SYNDROME X;
MONOTHERAPY;
PATIENT CARE;
PATIENT MONITORING;
PEER REVIEW;
PHYSICAL ACTIVITY;
PHYSICIAN ATTITUDE;
PRESCRIPTION;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
SHORT SURVEY;
STROKE;
TREATMENT OUTCOME;
WEIGHT REDUCTION;
|
|
EID: 41949098548
PISSN: 13565524
EISSN: None
Source Type: Journal
DOI: 10.1136/ebm.13.2.50 Document Type: Short Survey |
|
Times cited : (14)
|
|
References (2)
|
